NPRA GMP Cleanroom Design Requirements Malaysia 2026

For pharmaceutical manufacturers planning a new facility or retrofit, NPRA GMP requirements shape far more than the cleanroom particle count. In Malaysia, design decisions must support product quality, contamination prevention and documented qualification. The correct approach depends on whether the process is sterile or non-sterile, what materials are handled and how products move through the plant. This guide translates the current regulatory references into practical choices for layout, HVAC, testing and project procurement.

What GMP Standards Does NPRA Apply in Malaysia?

Malaysia’s National Pharmaceutical Regulatory Agency (NPRA) uses the PIC/S Guide to Good Manufacturing Practice for Medicinal Products as its GMP inspection reference. On 24 September 2026, NPRA adopted PE 009-18; this revision primarily updated Annex 19 on reference and retention samples, rather than rewriting cleanroom classifications. The key design references remain Part I Chapter 3 (Premises and Equipment), Chapter 5 (Production), Annex 1 (sterile medicinal products) and Annex 15 (Qualification and Validation).

A cleanroom passing an ISO 14644 particle classification test is not automatically a GMP-compliant pharmaceutical facility. GMP also examines process segregation, cleaning, personnel practices, environmental monitoring, documented controls and the wider quality system.

Sterile vs Non-Sterile GMP Cleanroom Classification

Annex 1 defines Grades A, B, C and D for sterile manufacture. Grade A protects critical exposed operations; Grade B is normally its background during conventional aseptic processing. Grades C and D support less critical sterile preparation steps, subject to the manufacturing process and risk assessment. The table shows Annex 1 classification limits for particles ≥0.5 µm, not routine monitoring action limits.

Grade

At rest (particles/m³)

In operation (particles/m³)

A

3,520

3,520

B

3,520

352,000

C

352,000

3,520,000

D

3,520,000

Risk-based

Source: PIC/S Annex 1, Table 1. ≥0.5 µm particle concentration.

Non-sterile tablet, capsule or other dosage-form facilities should not automatically copy an aseptic Grade A–D layout. Their environment and segregation strategy should follow product exposure, dust, microbiological and cross-contamination risks. ISO class and GMP grade are related concepts, but they are not interchangeable compliance labels.

Pharmaceutical Cleanroom Layout and Construction

PIC/S Part I Chapter 3 calls for logical production flow and spaces that reduce mix-ups and cross-contamination. Map personnel entry, gowning, raw-material receipt, dispensing, processing, packaging and waste exit before fixing room boundaries. For sterile facilities, the Annex 1 airlock rules are especially important: personnel and material transfer routes should be appropriately segregated, and doors to Grade A/B airlocks should be interlocked.

Where materials or products are exposed, walls, floors and ceilings should be smooth, non-shedding and readily cleanable. Avoid inaccessible recesses around services and provide maintainable seals and transitions. Early coordination with a pharmaceutical GMP cleanroom engineering team helps align the architectural layout with equipment, cleaning and qualification needs.

HVAC, HEPA Filtration and Contamination Control

Pharmaceutical cleanroom HVAC must deliver appropriate filtration, airflow patterns, temperature, humidity and pressure relationships under operating conditions. For adjacent sterile cleanrooms of different grades, Annex 1 gives a minimum 10 Pa pressure difference as a guidance value, while allowing justified modifications for hazardous-material containment. Critical pressure differences require monitoring and appropriate alarms.

For unidirectional airflow protecting exposed critical operations, Annex 1 provides a working-position air-speed guidance range of 0.36–0.54 m/s, unless another value is scientifically justified through the contamination control strategy (CCS). Neither this speed nor a fixed air-change rate is a blanket rule for every pharmaceutical room.

Malaysian projects also need deliberate humidity and condensation control because of the warm, humid climate. Discuss heat loads, dehumidification, filter access, air balancing and operating energy with the cleanroom HVAC design and HEPA filtration team before finalising equipment schedules.

How Does the Contamination Control Strategy Affect Design?

For sterile manufacturing, Annex 1 expects a facility-wide CCS connecting physical design with cleaning, disinfection, material transfer, operator behaviour, utilities and environmental monitoring. A HEPA filter or successful final-product test alone cannot replace a coordinated prevention strategy. Define contamination risks during the User Requirements Specification (URS) stage, then trace mitigation measures into drawings, procedures and qualification protocols.

Qualification, Testing and Requalification

Annex 15 sets out a lifecycle approach: URS establishes needs; Design Qualification (DQ) checks the proposed design; Installation Qualification (IQ), Operational Qualification (OQ) and Performance Qualification (PQ) provide documented evidence appropriate to the facility and its intended use. Applicable cleanroom tests include installed-filter integrity, airflow, pressure differential, airflow visualisation, particle classification and microbial or thermal measurements.

Under Annex 1, maximum periodic requalification intervals are six months for Grade A/B and 12 months for Grade C/D sterile areas. Significant facility or HVAC changes may trigger additional work. Agree test scope, acceptance criteria and deliverables with a cleanroom testing and validation provider before awarding the contract.

NPRA Inspection and Cleanroom Upgrade Requirements

For local manufacturers, NPRA’s Drug Registration Guidance Document, Appendix 27, addresses facility changes. Adding a manufacturing or packaging line, creating a production block or upgrading an existing production floor to a cleanroom are examples requiring a premises-layout submission under NPRA/431/12. Other changes may follow notification procedures; formal change control and risk assessment remain essential.

Inspection readiness should include current layout and airflow drawings, equipment and HVAC records, approved qualification reports, relevant operating procedures and Site Master File information. A contractor can supply engineering evidence, but regulatory compliance and inspection readiness remain the manufacturer’s responsibility.

GMP Cleanroom Procurement Checklist

Before requesting a quotation, specify the dosage form and process, sterile status, required room grades, exposed-product steps, personnel and material flows, hazardous substances, environmental setpoints, site constraints and validation responsibilities. Ask bidders to identify interfaces, exclusions, commissioning tests, documentation and the scope of NPRA-related layout support. Comparing only the construction price can conceal costly gaps at qualification and handover.

We'll call you

In order to serve you better, if you could kindly send an e-mail to nick@biogreenness.com for questions and details about your theoretical and special architectural plans, projects, and product specifications, your request will be responded to as soon as possible.


We'll call you

In order to serve you better, if you could kindly send an e-mail to nick@biogreenness.com for questions and details.


Leave a Reply

Your email address will not be published. Required fields are marked *

Please contact us for any cleanroom needs.

Let's have a chat